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reproduction in any medium, provided the original author and source are credited.SUMMARYAlthough the mammalian heart is one of the least regenerative organs in the body, recent evidence indicates that the myocardium
undergoes a certain degree of renewal to maintain homeostasis during normal aging. However, the cellular origin of cardiomyocyte
renewal has remained elusive due to lack of lineage tracing experiments focusing on putative adult cardiac precursor cells. We have
generated triple-transgenic mice based on the tet-cre system to identify descendants of cells that have expressed the stem cell marker
Sca1. We found a significant and lasting contribution of Sca1-derived cells to cardiomyocytes during normal aging. Ischemic damage
and pressure overload resulted in increased differentiation of Sca1-derived cells to the different cell types present in the heart. Our results
reveal a source of cells for cardiomyocyte renewal and provide a possible explanation for the limited contribution of Sca1-derived cells to
myocardial repair under pathological conditions.INTRODUCTION
Proliferation ofmammalian cardiomyocytes decreases after
birth, eventually resulting in an arrest of cell division
activity (Porrello et al., 2011), although adult cardiomyo-
cytes might enter the cell cycle under certain condi-
tions and undergo endoreduplication (Rumyantsev et al.,
1990). Limited proliferation of adult mammalian cardio-
myocytes is correlated with a restricted capacity of heart
regeneration, whereas fish and certain amphibian species
that own proliferating cardiomyocytes can readily regen-
erate even extensive cardiac injuries (Laflamme andMurry,
2011). Despite the low competence of mammals for heart
regeneration, several studies indicate that humans and
other mammals create new cardiomyocytes during their
lifetime, although no consensus exists about the degree
of replacement or the origin of newly formed cardiomyo-
cytes (Bergmann et al., 2009; Kajstura et al., 2010; Hsieh
et al., 2007). Recent studies suggest that under normal
physiological conditions, murine adult cardiomoycytes
are able to give rise to new cardiomoycytes at a rate of
1.3%–4% per year (Malliaras et al., 2013), while patho-
logical conditions seem to favor (limited) regeneration of
the myocardium both by preexisting cardiomyocytes and
by cardiac stem/progenitor cells (CSCs) (Senyo et al.,Stem Cell R2013). Numerous attempts have been made to identify
CSCs in the rodent heart, resulting in the identification
of cell populations that express cell surface markers (e.g.,
C-KITand SCA1 proteins), although their long-term contri-
bution to myocardial renewal is unknown due to the
absence of cell-tracing studies (Parmacek and Epstein,
2009). In addition, no specific marker has been identified
so far that can exclusively label CSCs. While the extent of
the contribution of endogenous CSCs to myocardial repair
in response to heart injury is unknown, clinical trials based
on the use of heart-derived cells have yielded encouraging
results (Ptaszek et al., 2012). In this report, we assess the fate
of Sca1-positive cells in the myocardium using various
cell lineage tracing approaches to analyze whether CSCs
contribute to the turnover of cardiomyocytes during
physiological aging and after myocardial injury.RESULTS
Cardiomyocytes Do Not Express SCA1 in Healthy
or Injured Hearts
Numerous reports demonstrated that the heart contains
Sca1-positive cells (Holmes and Stanford, 2007). To learn
more about the identity of cells that express SCA1 in theeports j Vol. 1 j 397–410 j November 19, 2013 j ª2013 The Authors 397
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Lineage Tracing Sca1-Positive and -Derived Cellsheart, we stained sections of murine hearts with anti-SCA1
antibody in combination with phalloidin, which provided
a general overview of the myocardial morphology. We
tested cardiomyocytes at different ages (Figure 1A; Figure S1
available online) and various physiological and patho-
logical conditions (pressure overload induced hypertrophy
by transverse aortic constriction [TAC]; Figure 1B) and did
not detect any that expressed SCA1 protein; rather, Sca1-
positive cells were identified in the stromal compartment
of the myocardium, probably representing pericytes and
mesenchymal and endothelial cells. Although several
different SCA1 antibodies and reaction conditions were
employed to achieve the highest possible sensitivity, we
wondered whether we might have missed some Sca1-
positive cells. To answer this question, we used Sca1-GFP
reporter mice, which have been previously demonstrated
to faithfully recapitulate endogenous expression of Sca1
gene (Ma et al., 2002). Cardiomyocytes positive for GFP
were not detected both in physiological and pathological
conditions (myocardial infarction [MI]; Figures 1C and
1D). Indeed, Sca1-GFP positive cells were again seen only
in the myocardial stroma, mainly in endothelial cells, as
indicated by costaining with BS-1 (Bandeiraea simplicifolia)
lectin (Figure 1E). To further corroborate these findings and
to eliminate possible staining artifacts, cardiomyocytes
were isolated from C57BL/6 wild-type and Sca1-GFP
reporter mice and analyzed for SCA1 expression. No Sca1-
GFP activity was seen in cardiomyocytes, although we
readily detected SCA1 expression in small cells that
are closely associated with cardiomyocytes (Figures 2A
and 2B).
The association of some Sca1-positive cells with cardio-
myocytes (identified both with anti-SCA1 antibodies and
by Sca1-GFP expression) came as a surprise, because
stringent conditions were employed to dissociate the
myocardium and to obtain single-cell suspension of cardi-
omyocytes. The location of these Sca1-positive cells
reminded us of skeletal muscle stem cells called ‘‘satellite
cells’’ (Mauro, 1961; Gu¨nther et al., 2013). Satellite cells
are located onmyofibers but below the basal lamina, whichFigure 1. SCA1 Is Not Expressed in Cardiomyocytes
(A and B) Cross sections of murine hearts stained with anti-SCA1 ant
Normal heart of a 4-month-old C57BL/6 mouse. (B) Hypertrophied h
transverse aortic constriction (TAC) for 4 weeks.
(C) Cross sections of a normal heart of a 2-month-old Sca1-GFP mous
visualize cardiomocytes.
(D) Cross sections of a heart of a 4-month-old Sca1-GFP mouse, which
with anti-GFP antibody (green) to identify Sca1-positive cells and ph
(E) Cross sections of a heart of a 4-month-old Sca1-GFP mouse, which
(green) to identify Sca1-positive cells and BS-1 (red) to identify endo
nuclei (blue).
See also Figure S1.
Stem Cell Rcontains laminin. Staining for laminin revealed that Sca1-
positive cells tightly associated with cardiomyocytes are
indeed located under the basal lamina (Figure 2C), which
might provide a niche for such cells. Quantitative analysis
revealed that 430 out of 5,031 isolated cardiomyocytes
(8.55%) carried Sca1-positive cells under the basal lamina.
Interestingly, some Sca1-positive cells expressed C-KIT,
CD34, ABCG2, and/or SOX2 (Figures 2D–2F), which are
typical markers for adult stem cells in various tissues
including skeletal muscle (Panne´rec et al., 2012; Uchida
et al., 2011; Yin et al., 2013). However, the number of
SCA1 and C-KIT double positive cells was rather low as
determined by flow cytometry (Figure S2). Only 0.4% ±
0.2% of all mononuclear, noncardiomyocytic cells isolated
from the myocardium were positive for SCA1 and C-KIT
and negative for the endothelial cell marker CD31 and
the hematopoietic marker CD45 (CD31/CD45/SCA1+/
C-KIT+). In total, 23.9% ± 3.7%of allmononuclear, noncar-
diomyocytic cells expressed SCA1, but not CD31 andCD45
(SCA1+/CD31/CD45), compared to 0.6% ± 0.3% of
C-KIT+/CD31/CD45 cells.
Sca1-Derived Cells Give Rise to Cardiomyocytes
To investigate whether Sca1-positive cells in the myocar-
dium contribute to the homeostasis of the myocardium
and more specifically to the turnover of cardiomyocytes,
we generated a tet-off mouse line (Sca1-tTA) employing
the same Sca1 genomic fragment (14 kb of the Ly-6A
gene) used to establish the Sca1-GFP reporter strain (Ma
et al., 2002). Thereafter, Sca1-tTA mice were crossed to
LC1-Cre mice, in which expression of cre-recombinase is
tightly controlled by the tet-system (Scho¨nig et al., 2002),
and to Z/AP reporter mice (Lobe et al., 1999). The resulting
Sca1-tTA//LC1-Cre//Z/AP mice (Figure 3B) allow doxycy-
cline-dependent expression of cre-recombinase (‘‘tet-off’’-
system), which will permanently activate human placental
alkaline phosphatase expression in cells that have
expressed Sca1 (Figure 3C). To rule out potential artifacts,
we rigorously analyzed our genetic tracing system. We
did not find any alkaline phosphatase (AP)-positive cellsibody (red) and phalloidin (white) to visualize cardiomocytes. (A)
eart of a 4-month-old C57BL/6 mouse, which was challenged with
e stained with anti-GFP antibody (green) and phalloidin (white) to
was challenged with myocardial infarction (MI) for 4 weeks, stained
alloidin (red) to identify cardiomyocytes.
was challenged with MI for 4 weeks, stained with anti-GFP antibody
thelial cells. All sections were counterstained with DAPI to visualize
eports j Vol. 1 j 397–410 j November 19, 2013 j ª2013 The Authors 399
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Lineage Tracing Sca1-Positive and -Derived Cellsin the absence of the Sca1-tTA allele (Figure 3D) up to
18 months of age (Figures 3E and 3F), confirming previous
results about the regulation of the LC1-Cre locus (Scho¨nig
et al., 2002). We did not detect a GFP signal in Sca1-tTA
mice by immunofluorescence analysis or western blotting,
although a GFP gene was inserted behind the tTA gene
using an internal ribosome entry site (IRES) (Figure 3A),
probably due to the relatively low efficiency of the IRES.
To determine the identity of Sca1-derived AP-positive
cells in Sca1-tTA//LC1-Cre//Z/AP mice, we performed sys-
tematic triple staining of consecutive cross sections of the
heart using antibodies directed against AP and different
cell-type-specific markers (BS-1 for endothelial cells and
a-smooth muscle actin for smooth muscle cells). Cardio-
myocytes were identified by expression of dystrophin,
which delineates cellular boundaries, allowing a clear sepa-
ration of cardiomyocytes from other cell types (e.g., endo-
thelial cells). In addition, wheat (Triticum vulgaris) lectin
was used to label all cellular membranes and DAPI was
used to visualize nuclei. Initially, we used mice that were
not treated with doxycycline and hence produce active
tTA, allowing continuous labeling of cells that express
Sca1 gene during the lifetime of the animal, including
embryogenesis.We found that virtually all AP-positive cells
expressed either BS-1, dystrophin, or a-smooth muscle
actin (Figures 3H–3J). Because cardiomyocytes do not ex-
press SCA1 under physiological and pathological condi-
tions as described above, we concluded that Sca1-derived
cells are able to generate cardiomyocytes; we concentrated
on this conclusion during the further course of the study.
To rule out that newly emerging AP-positive cardiomyo-
cytes were generated by rare fusion events, we isolated
cardiomyocytes from 2-month-old male Sca1-tTA//LC1-
Cre//Z/AP mice and subjected them to fluorescence
in situ hybridization (FISH) analysis using a Y chromosome
probe. We found that 18.88% ± 2.97% of isolated AP-
positive cardiomyocytes contained one nucleus with one
Y chromosome, while 8.06% of all mononucleated cells
were AP positive (Figures 3K–3Q). Of note, previous studies
have reported conflicting numbers of mononucleated
cardiomyocytes, ranging from 2% (Walsh et al., 2010) to
18% (Brodsky et al., 1980), which is most likely due to
the different techniques used. Most researchers, whoFigure 2. Some Sca1-Positive Cells Are Attached to Cardiomyocyt
(A) Identification of Sca1-positive cells attached to isolated cardiom
(B) Staining with an anti-SCA1 antibody (red) and with an anti-GFP
(C) Staining with anti-SCA1 antibody (red) and anti-laminin antibody
cells were stained with phalloidin (white) to visualize cardiomyocyte
(D–G) Sca1-positive cells attached to cardiomyocytes were identifie
antibodies against C-KIT (red) (D), CD34 (red) (E), ABCG2 (red) (F), o
visualize nuclei.
See also Figure S2.
Stem Cell Rcame up with a relatively high number of binucleated
cardiomyocytes (>80%) (Brodsky et al., 1980; Liao et al.,
2001; Soonpaa et al., 1996; Walsh et al., 2010), employed
flow cytometry analysis, whereas our data are based on
microscopic analysis of the number of nuclei in isolated
cardiomyocytes. Because AP-positive cardiomyocytes
with one nucleus and one Y chromosome cannot be gener-
ated by a cell fusion event, we concluded that AP-positive
cardiomyocytes originated from differentiating Sca1-
positive cells.
Although previous reports (Oh et al., 2003; Goumans
et al., 2007) indicated that Sca1-derived cells generate cardi-
omyocytes and other cell types in vitro, the question re-
mained whether a common Sca1-progenitor cell exists
in vivo that can give rise to all three lineages of the heart
under physiological conditions similar to secondary heart
field progenitor cells (Chien et al., 2008). Alternatively,
multiple unipotential cell populations all expressing Sca1
might differentiate into distinct lineages. To explore these
possibilities, we took advantage of the R26R-Confetti re-
porter line (Snippert et al., 2010), which, in combination
with Sca1-tTA and LC1-Cremice, clonallymarks distinctive
populations of Sca1-derived cells (Figures 4A and 4B). The
R26R-Confetti allele carries a stochastic multicolor cre-
recombinase reporter with four fluorescent proteins (GFP
with nuclear localization signal [nGFP], monomeric
enhanced yellow fluorescent protein [YFP], red fluorescent
protein [RFP], and mCerulean fluorescent protein [CFP]).
After stochastic cre-mediated recombination, only one of
the four fluorescent proteins will be expressed in each
single cell and hence label individual clones (Figure 4C).
Costaining with phalloidin and localization of labeled cells
clearly identified some Sca1-derived cells as cardiomyo-
cytes (Figures 4D and 4E). Interestingly, in the majority of
cases, cells from an individual clone belonged to a single
lineage. It was rare that cardiomyocytes carrying the same
label were found within the same area. Instead, we
observed differentially labeled cells of the same lineage in
close proximity, which argues for limited expansion of
Sca1-derived clones and mixing of clones of the same line-
age. Furthermore, quantitative evaluation of labeled cells
revealed an unequal distribution of the four cellular labels
among all marked cells, marked cardiomyocytes, andes and Situated Underneath the Same Basal Lamina
yocytes with an anti-SCA1 antibody (red).
antibody (green) to simultaneously detect SCA1 and Sca1-GFP.
(green) to label Sca1-positive cells under the basal lamina. Isolated
s.
d with an antibody against Sca1-GFP (green) and costained with
r SOX2 (red) (G). All slides were counterstained with DAPI (blue) to
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Figure 3. Characterization of Sca1-tTA//LC1-Cre//Z/AP Mice
(A) Western blot analysis of GFP expression in hearts of C57BL/6 (negative control), Sca1-tTA, and Sca1-GFP mice (positive control). No
GFP expression was monitored in Sca1-tTA mice. An antibody against pan-actin was used as a loading control.
(legend continued on next page)
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Lineage Tracing Sca1-Positive and -Derived Cellsmarked noncardiomyocytes in nine out of ten different
areas (Figure 4F). These data indicate that Sca1-derived cells
possess a strong bias, which prevents cardiomyocyte pro-
genitor cells to generate equal numbers of noncardiomyo-
cytes (such as smoothmuscle cells) and vice versa. It should
be emphasized that our conclusion about the restricted
lineage potential and limited expansion of Sca1-derived
cells relies on the absence of extensive migration within
the myocardium. Since two of the four colors remain in
the R26R-Confetti allele after initial cre-mediated recombi-
nation (blue with red or green with yellow), it is possible
that continuous cre activity will induce ‘‘flipping’’ from
the active color to the silent color, thereby creating a bias
in the distribution of colors (either nGFP/YFP or RFP/
mCFP) (Schepers et al., 2012). However, an unequal distri-
bution of cell-type-specific color groups was evident even
when only two colors were examined, supporting our
initial conclusion about the limited lineage potential of
Sca1-positive CSCs.
Sca1-Positive Cells Contribute Continuously to
Cardiomyogenesis during Physiological Aging
Next, we studied changes in the number of Sca1-derived
AP-positive cells in the normally aging myocardium,
guided by the assumption that homeostatic replacement
of cardiomyocytes and other cell types in the heart might
result in an increase of AP-positive cells (Figure 5; Table
S1). The largest increase was scored in 13- and 18-month-
old hearts in which the number of labeled cells increased
more than 3-fold (27.46 ± 0.64 and 87.40 ± 15.73 labeled
cells per mm2 for 13- and 18-month-old hearts, respec-
tively). The relative distribution of different AP-labeled
cell types remained similar up to 8 months of the age.
From this time point onward, the contribution of cardio-
myocytes relative to all labeled cells increased to 4.55% ±(B) Scheme for breeding of Sca1-tTA//LC1-Cre//Z/AP mice.
(C and D) Cross sections of hearts from 2-month-old Sca1-tTA //LC1-
control) mice (D) stained for AP activity.
(E and F) Cross sections of hearts of an 18-month-old female LC1-Cre//
b-gal (X-Gal) and (F) AP activity (NBT/BCIP). The ubiquitous activity
absence of Sca1-tTA indicate tight, tTA-dependent regulation of the
(G) Triple staining for labeled cells (anti-AP antibody, green), nuclei (
the inset indicates a rare SCA1 (marked by a white arrow) and AP (m
(H–J) Triple staining for labeled cells (anti-AP antibody, green), nuc
(H) dystrophin (red) for cardiomyocytes, (I) smooth muscle actin (re
(K and L) Number of nuclei and ploidy of AP-positive (Sca1-derived) an
frommale Sca1-tTA//LC1-Cre//Z/AP mice and subjected to FISH using
anti-AP antibody and DAPI staining. Mononuclear cardiomyocytes w
fusion events. Two Sca1-tTA//LC1-Cre//Z/AP male mice were used fo
(M–Q) Examples of isolated AP-positive and AP-negative cardiomy
expression was detected with an anti-AP antibody (green) and nucle
positive cardiomyocyte with a single Y chromosome in (M) and a binu
in (Q).
Stem Cell R0.87% of cardiomyocytes at 13 months. However, at the
age of 18 months, the share of labeled cardiomyocytes
dropped to 2.57% ± 1.38%. This might be explained by a
major increase of noncardiomyogenic AP-labeled cells
between 13- and 18-month-old hearts. Our results suggest
that the heart replaces cardiomyocytes at a constant rate
during aging from Sca1-derived cells until at least
18 months.
Cardiac Damage and RemodellingModestly Stimulate
the Generation of Sca1-Derived Cells
To investigate the generation of new Sca1-derived cardio-
myocytes under pathological conditions, we challenged
3-month-old Sca1-tTA//LC1-Cre//Z/AP mice by MI. Inter-
estingly, very few AP-positive cells were found in the
infarcted area and in the border zone (Figures 6A–6E). In
contrast, clusters of AP-positive, BS-1-positive endothelial
cells emerged in the septum, whereas the number of AP-
positive cardiomyocytes remained constant in the post-
MI heart (Figure 6D; Table S2). We concluded that the
compensatory hypertrophy of the septum, in response to
the loss ofmyocardial tissue within anterior walls, supports
increased recruitment of Sca1-derived endothelial cells. In
contrast, conditions in the border zone seem to prevent
differentiation of Sca1-positive cells, which otherwise
might have allowed replacement of scar tissue by func-
tional myocardium.
In addition, we asked whether pressure-induced cardiac
hypertrophy caused by TAC would promote generation of
new Sca1-derived cardiomyocytes. Four weeks after the
operation, the number of AP-positive cardiomyocytes per
mm2 had increased more than 3-fold (0.17 ± 0.06 and
0.57 ± 0.10 for the aged-matched and TAC-operated hearts,
respectively), while the total number of AP-labeled cells
per mm2 did not change significantly (18.68 ± 6.40 forCre//Z/AP (C) and LC1-Cre//Z/AP (without Sca1-tTA as a negative
Z/AP mouse (without Sca1-tTA as a negative control) stained for (E)
of the lacZ reporter and the lack of AP-reporter gene activity in the
LC1 locus.
DAPI, blue), and SCA1 (anti-SCA1 antibody, red). The arrowhead in
arked by a white arrow) coexpressing cell.
lei (DAPI, blue), and the following cell-type-specific markers (red):
d) for smooth muscle cells, and (J) BS-1 (red) for endothelial cells.
d AP-negative cardiomyocytes. Adult cardiomyocytes were isolated
a Y chromosome-specific probe followed by immunostaining with an
ith a single Y chromosome are unlikely to be derived from cellular
r this experiment. Error bars represent SDs.
ocytes after FISH with a Y chromosome-specific probe (red). AP
i were visualized by DAPI staining (blue). Note a mononuclear AP-
clear cardiomyocyte carrying one nucleus with two Y chromosomes
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Figure 4. Sca1-Derived Cells Undergo Limited Expansion into Distinct Lineages
(A) Outline of the strategy to generate Sca1-tTA// LC1-Cre//R26R-Confetti mice.
(B) Schematic representation of potential labeling results using Sca1-tTA//LC1-Cre//R26R-Confetti mice. Single multipotential
Sca1-positive clones will give rise to different cell types in the heart (e.g., cardiomyocytes, endothelial cells, and smooth muscle cells)
with the same color (e.g., red CSC, red cardiomyocytes, red endothelial cells). Single unipotential Sca1-positive clones will give to a single
cell type (e.g., cardiomyocytes), all of which have the same color.
(C) Representative example of the clonal expansion of labeled Sca1-derived cells.
(D) Costaining of the same heart section as shown in (C) with phalloidin (in gray). The arrows indicate the contribution of Sca1-derived
cells to smooth muscle cells and the asterisks to cardiomyocytes.
(E) Confocal image of a cardiomyocyte derived from a Sca1-derived clone marked in yellow and costained with phalloidin (in gray).
(F) Doughnut chart of the distribution of cardiomyocytes (inner doughnut chart), noncardiomyocytes (middle doughnut chart), and all
labeled cells (outer doughnut chart) in ten different areas of the myocardium. The size of the labeled boxes represents the frequency of
labeled cells in percent. Bold black lines were used to separate each area of counted cells. The unequal distribution of colors for different
cell types in most areas excludes that cell types and color are related (p > 0.96 by chi-square test), arguing for distinct progenitor cells for
different lineages.
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Lineage Tracing Sca1-Positive and -Derived CellsTAC-operated and 13.79 ± 6.50 for the aged-matched
hearts) (Figures 6F and 6H; Table S3). Five months after
the operation, we scored a 2-fold-higher number of AP-pos-
itive cardiomyocytes (0.84 ± 0.49 for TAC-operated and404 Stem Cell Reports j Vol. 1 j 397–410 j November 19, 2013 j ª2013 The0.4 ± 0.15 for the aged-matched hearts) and of the total
number of AP-positive cells (compared to the age-matched
hearts [8 months old]) (45.15 ± 7.46 for TAC-operated and
15.23 ± 2.94 for the aged-matched hearts) (Figure 6H).Authors
Figure 5. Contribution of Sca1-Derived Cells to Different Cell
Lineages in the Heart during Normal Aging
(A) Relative distribution of AP-labeled endothelial/interstitial cells
(gray), smoothmuscle cells (black), and cardiomyocytes (yellow) at
different postnatal stages in percent.
(B) The number of Sca1-derived cardiomyocytes increases
continuously in the postnatal heart. A nearly linear increase of
Sca1-derived cardiomyocytes over time was calculated. The number
of AP-labeled cardiomyocytes is shown as labeled cells per mm2.
See also Table S1.
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Lineage Tracing Sca1-Positive and -Derived CellsThese data indicate that Sca1-positive progenitor cells are
more responsive to inductive cues that promote differenti-
ation into cardiomyocytes in healthy compared to the
diseased myocardium.
Sca1-Derived Cardiomyocytes Are Present in Postnatal
Hearts
The continuous increase of Sca1-derived cardiomyocytes
from 2 to 18 months proved that new cardiomyocytes
were generated postnatally (Figure 5) but did not revealStem Cell Rwhether these cells were generated directly from Sca1-
positive progenitor cells present in the postnatal heart
(Miles et al., 1997). To address this point, we took advan-
tage of our conditional tet-off system to suppress labeling
by administration of doxycycline to pregnant mice either
permanently or until shortly after birth (Figure 7A). Stain-
ing of hearts from doxycycline-treated animals revealed
the absence of AP-positive cells, confirming tight regula-
tion of tTA-dependent cre recombinase expression and
the validity of our cell tracing approach (Figure 7B). In a
complementary experiment, we suppressed labeling after
birth, which restricts tracing to cells that have expressed
Sca1 before birth. At 2 months of age, mice receiving doxy-
cycline either until or after birth were compared (Figures
7C–7E; Table S4). We found that suppression of labeling
before birth did not result in a reduction of AP-positive
cardiomyocytes but did increase the relative number of car-
diomyocytes. Similarly, the suppression of labeling after
birth led to an amplification of the number of cardiomyo-
cytes, indicating that some Sca1-positive cells were
committed to the cardiomyogenic lineage before birth.
The increase of cardiomyocytes after doxycycline treat-
ment went along with a general increase of the number
of labeled cells permm2. The relative decrease of AP-labeled
nonmuscle cells and the increase of cardiomyocytes
initially came as a surprise. However, we noted that treat-
ment with doxycycline resulted in a significant reduction
in the size of the hearts while the heart/body-weight ratio
remained constant (Figure 7F), which might be explained
by the suppression of angiogenesis by doxycycline (Fainaru
et al., 2008). We concluded that the increase of cardiomyo-
cytes after doxycycline treatment is, at least in part, due to
the relative decline of nonmuscle cells and the smaller size
of the heart. Taken together, the generation of AP-positive
cardiomyocytes after the suppression of labeling before
birth and the increase in AP-positive cells after birth clearly
demonstrate that a subpopulation of cardiomyocytes is
derived from adult Sca1-positive cells.DISCUSSION
Our study provides clear evidence for the continuous
replacement of myocardial cells by Sca1-positive CSCs,
avoiding the potential problems associated with previously
used labeling methods (Bergmann et al., 2009; Kajstura
et al., 2010). Yet it is clear that our strategy has limitations.
We focused on the contribution of a distinct subset of
potential CSCs, which automatically excludes other puta-
tive CSCs. Therefore, we might have systematically under-
estimated the extent of myocardial turnover. Moreover,
there is no consensus about the rate of cardiac regeneration
in mammals. Some studies demonstrated very little, if any,eports j Vol. 1 j 397–410 j November 19, 2013 j ª2013 The Authors 405
Figure 6. Pressure-Induced Cardiac Hypertrophy but Not Myocardial Infarction Leads to a Moderate Increase of Sca1-Derived
Cardiomyocytes
(A) Trichrome staining of a section from 4-month-old mice (1 month after MI). The areas stained in (B)–(E) are indicated by black boxes.
(B–E) Triple labeling of areas from different regions of post-infarcted hearts stained for collagen I (red), AP (anti-AP antibody, green), and
nuclei (DAPI, blue). Areas bordering the scar (B and E, identified by massive deposition of collagen I) or within the scar (C) show a
reduction of Sca1-derived cells. An increase of Sca1-derived cells (green) was found in areas showing compensatory hypertrophy (D).
(F) AP-staining of cross sections of 4- and 8-month-old mice subjected to TAC at 3 month of age and of control mice.
(G) Number of all Sca1-derived cells in hearts of TAC-operated and control mice at 4 and 8 months of age.
(H) Number of Sca1-derived cardiomyocytes in hearts of TAC-operated and of control mice at 4 and 8 months of age (n = 4 mice for
4-month-old TAC-operated samples and n = 3 mice for all the other conditions).
Values in (G) and (H) are given in numbers of AP-positive cells per mm2. See also Tables S2 and S3.
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whereas other studies in humans reported replacement of
about 45% of all cardiomyocytes during the whole lifetime
or even a full replacement of all cardiomyocytes within 5
years (reviewed in Laflamme and Murry, 2011). All these
issues make it difficult to determine the relative contribu-
tion of Sca1-derived cells to myocardial renewal. Under
any circumstance, our results demonstrate that at least a
few percent of cardiomyocytes are replaced by Sca1-derived
cardiomyocytes during normal aging.
Our analysis revealed that Sca1-positive cells in the heart
can give rise to cardiomyocytes. It also seems likely that
Sca1-positive stromal cells differentiate to endothelial cells
(Hoch et al., 2011), but unequivocal proof for this hypoth-
esis is difficult to obtain because some endothelial cells also406 Stem Cell Reports j Vol. 1 j 397–410 j November 19, 2013 j ª2013 Theexpress Sca1. Furthermore, the use of the R26R-Confetti re-
porter line enabled us to demonstrate that individual
Sca1-positive cells own a restricted potential for expansion
and usually give rise only to a single cell type. This feature
distinguishes adult CSCs from embryonic secondary heart
field progenitor cells, which have the potential to differen-
tiate into cardiomyocytes, smooth muscle, or endothelial
cells (Chien et al., 2008). Despite the presence of abundant
numbers of Sca1-positive cells in the heart, only a small
subset of Sca1-positive cells differentiated into cardiomyo-
cytes in our study. This observation might explain the
limited contribution of Sca1-positive CSC to the adult
myocardium. Furthermore, it is tempting to speculate
that heterogeneity of Sca1-positive cells is one of the major
reasons why different groups obtained conflicting dataAuthors
Figure 7. Embryonic and Postnatal Sca1-Positive Cells Contribute to Different Cell Lineages in the Heart
(A) A schematic timeline of doxycycline (dox) administration in Sca1-tTA//LC1-Cre//Z/AP mice.
(B) An AP-stained cross section of hearts from mice continuously treated with dox.
(C) An AP-stained cross section of hearts from mice treated with dox until birth.
(D and E) Relative distributions of AP-labeled endothelial cells, smooth muscle cells, and cardiomyocytes in Sca1-tTA-Cre//LC1-Cre//Z/AP
mice at 2 month of age that received dox until birth (D) and after birth (E). The statistical test based on Student’s unpaired heteroscedastic
t test with a one-tailed distribution indicates that there is no statistically significant difference between dox until birth and after birth for
each cell type (cardiomyocytes: p = 0.07; smooth muscle cells: p = 0.148; and endothelial cells: p = 0.179).
(F) Administration of dox resulted in decrease of heart sizes. The decrease of heart sizes after dox treatment is reflected by different
cross-sectional areas (displayed as mm2) of hearts of dox-treated and untreated mice at midventricular levels.
See also Table S4.
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(Hoch et al., 2011; Holmes and Stanford, 2007; Matsuura
et al., 2004; Tateishi et al., 2007). Clearly, further efforts
are needed to characterize different populations of CSCs
and to explore how endogenous CSCs can be protected
and stimulated in order to enhance cardiac repair beyond
normal limits.EXPERIMENTAL PROCEDURES
Mice
Triple-transgenic mice were obtained by breeding Sca1-tTA with
LC1-Cre (Scho¨nig et al., 2002) and Z/AP (Lobe et al., 1999) or
R26R-Confetti (Snippert et al., 2010) reporter mice. Sca1-tTA mice
were generated by pronucleus injectionusing standard procedures.
Construction of the transgene was based on the insertion of
the tetracycline transactivator (tTA)-IRES-GFP-polyA cassette
(2.6 Kb) into the ClaI site of pPOLYIII-Ly6A, which contains
sequences of the Sca1 genomic region (Ma et al., 2002). All strains
were maintained on a C57BL/6 genetic background after back-
crossing. Doxycycline was administered in drinking water at
1 mg/ml together with 30 mg/ml sucrose.Stem Cell RMyocardial Infarction and Transverse Aortic
Constriction
MI was achieved by permanent ligation of the left anterior
descending coronary artery as described previously (Belema-
Bedada et al., 2008). Transverse aortic constriction was accom-
plished by applying a Weck hemoclip to the proximal aorta,
resulting in an acute left-ventricular pressure overload (Kreymborg
et al., 2010). All animal experiments in this study were performed
with approval of the local animal care committee.
Antibody, Histochemical, and Histological Staining
Dissected hearts were washed in PBS, snap-frozen in liquid nitro-
gen, and stored at 80C until further use. 6 mm sections were
prepared on a cryostat before fixation in 4% paraformaldehyde.
Reaction of sections with primary and secondary antibodies
followed established protocols (Belema-Bedada et al., 2008). Nuclei
were stained with DAPI. All antibodies used in this study are
described in Table S5.
To stain for AP activity, cryosections were fixed with
0.4% glutaraldehyde, heated at 70C for 30 min in PBS, and
incubated in NTMT buffer for 30 min at room temperature.
The color was developed in NBT/BCIP staining solution at 37C
for 2 hr.eports j Vol. 1 j 397–410 j November 19, 2013 j ª2013 The Authors 407
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performing the X-Gal reaction first. After washing in PBS three
times, sections were permeabilized with 0.05% Triton-X at room
temperature for 10 min and washed in PBS three times. The anti-
body against SCA1 (Abcam) was diluted at 1:100 in 0.005%
Triton-X and 0.1% BSA and incubated at 4C for overnight. The
next day, sectionswerewashed three times in PBS. Bound antibody
was visualized by the rat Vectastain Elite ABC kit (Vector
Laboratories, #PK-6104) using the DAB Plus Substrate Staining
System (Thermo Scientific, #TA-060-HDX). The reaction with
DAB substrate was performed for 5 min and stopped by washing
slides with tap water.Counting of Immunofluorescence Stained Cells
To determine the numbers of differentially stained cell types, at
least 20 sections were prepared for each staining from each indi-
vidual heart by collecting ten consecutive sections on individual
slides. Next, the procedure was repeated, yielding ten slides with
two sections on each slide. Slides were reacted with a series of
antibodies indicated in the main text. In a stained section, all
labeled cells were counted by switching between fluorescent filters
(blue for DAPI, green for AP, and red for cell type) tomake sure that
individual cells were only counted once. In some cases, when cells
were lying on top of each other (especially in the case of endothe-
lial cells), the stage of fluorescent microscope was adjusted, guided
by the nuclear DAPI stain, to make sure that individual cells were
counted. To avoid investigator-dependent bias, all sections were
independently counted by two different persons and checked for
consistency. When numbers of counted cells differed significantly
between two sections on one slide, the same staining scheme was
repeated with an extra slide. To calculate the percentage of cell
types, the number of AP-positive, cell-type-marker-positive cells
was divided by number of AP-positive, lectin-positive cells. To
derive p values, the Wilcoxon Mann-Whitney test was applied in
R. Results are presented as mean ± SEM.
To define a clonal expansion of labeled Sca1-derived cells in the
hearts of Sca1-tTA//LC1-Cre//R26R-Confetti mice, ten fields were
randomly chosen from each section of the heart using340magni-
fication on confocal microscope and a picture was taken. This
picture is defined as one area. Then, the number of labeled cells
with one of four colors was counted separately. To identify labeled
cardiomyocytes, merged images were examined for phalloidin-
positive cells.Confocal Microscope
Pictures were acquired using a confocal microscope (Leica SP2).
Each picture was been taken using scan mode xyz, format of
1,024 3 1,024 pixels, speed at 400 Hz, image x and y dimensions
of 238.10 mm, voxel-size of 231.51 3 231.51 nm 3 nm, average
line 1, average frame 3, and pinhole 1. The z stack was done with
a pitch of 0.5 mm (the stack calculation was of 10 mm), and 20
pictures were acquired. Snapshots of the z stack pictures were
done using Leica Confocal software. The objectives used were
HCXPL APO CS 403 1.25 oil and HCXPL APO lbd BL 633 1.4
oil. The lasers considered were 405 nm, 488 nm, 514 nm,
564 nm, 564 nm, and 633 nm. Adobe Photoshop CS4 was used
to adjust the brightness and contrast of the picture (in RGB color408 Stem Cell Reports j Vol. 1 j 397–410 j November 19, 2013 j ª2013 Themode), the white and black levels, and the merge of the different
channels, when necessary. Each picture was adjusted to a width
of 6 cm and a resolution of 300 pixels/inch.
Cardiomyocyte Isolation
Cardiomyocytes were isolated as previously published (O’Connell
et al., 2003). Isolated cardiomyocytes were allowed to attach
to chamber slides coated with laminin overnight followed by
staining of attached cardiomyocytes.
Fluorescent In Situ Hybridization
Isolated cardiomyocytes were stained with mouse IDetect Chr Y
FISH Paint Probe Red (Labs Inc Biotechnology) as described
previously (Zheng et al., 2007). Immunofluorescence staining of
FISH-hybridized cells was performed as described above. For
counting, ten randomly selected fields were examined.
Western Blot Analysis
Tissue samples were homogenized by sonication in the presence of
proteinase inhibitors and heated for 1 min at 99C. Protein
samples (20 mg) were resolved on a 4%–12% SDS polyacrylamide
gradient gel (Life Technologies) and blotted onto a nitrocellulose
membrane. Bound antibodies were visualized using VersaDoc MP
Systems (Bio-Rad) and the Femto detection kit (Thermo Scientific)
according to the manufacturer’s instructions.
Flow Cytometry Analysis
Adult mouse hearts (female, 8 weeks of age) were cut into small
pieces (1–2 mm in diameter) and digested with collagenaseD
(Roche) and DNase I (Serva) for 30 min at 37C. Red blood lysis
was performed using sterile filtered deionized water followed by
two washing steps with PBS. Debris was removed with a 30 mm
filter. The resulting single-cell suspension was preincubated with
blocking rat-mouse antibodies to the FcRg III/II receptor (clone
2.4G2; BD Biosciences) before staining with primary anti-
bodies. The following conjugated primary antibodies were used:
fluorescein isothiocyanate mouse anti-CD45.2 (clone 104),
phycoerythrin-conjugated anti-C-KIT (2B8), peridinin chlorophyll
protein-eFluor710 conjugated anti-CD31 (clone 390), and
allophycocyanin-conjugated anti-Sca1 (Ly-6A/E, clone D7; all
from eBioscience). FACS data were obtained by analyzing
100,000 live cells (DAPI negative) in the stem cell gate (FSC-A
and SSC-A) using appropriate isotype controls. Measurements
were accomplished with a FACS Canto II instrument (BD
Biosciences) and analyzed with FlowJo software (TreeStar).
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